Urethral Cancer

Urethral Cancer is a rare malignancy affecting the urethra, the tube responsible for expelling urine from the bladder. Early detection and comprehensive treatment are crucial for managing this condition effectively. Dr. Prabhat Ranjan, a distinguished urologist, specializes in diagnosing and treating urethral cancer, offering patients personalized care tailored to their unique needs.

Common Signs of Urethral Cancer

Symptoms of Urethral Cancer

The most common symptom of urethral cancer is hematuria, or blood in the urine, which may appear as pink, red, or brown discoloration. Patients often experience pain or burning during urination, similar to the symptoms of a urinary tract infection. Other urinary symptoms include weak urine flow, difficulty starting or maintaining urination, and urinary incontinence.

A lump, swelling, or thickening in the perineal area or around the urethra is another common indicator. In advanced cases, there may be pelvic pain, discomfort during sexual activity, or signs of urinary obstruction. Persistent symptoms warrant prompt medical evaluation to rule out urethral cancer or other urological conditions.

Diagnosis and Treatment Options

Dr. Ranjan employs advanced diagnostic techniques, including:

Physical Examination: To assess any abnormalities in the urethral area.
Cystoscopy: A procedure to visually inspect the urethra and bladder.
Biopsy: To confirm cancer diagnosis.
Imaging Tests: MRI, CT scans, or ultrasounds to check for cancer spread.

Treatment Options

Surgery: Removal of cancerous tissue, which may include partial or total urethrectomy.
Radiation Therapy: Targeted treatment for localized cancer.
Chemotherapy: For advanced or metastatic cases.
Laser Therapy: For smaller, early-stage tumors.

Prevention Strategies

Dr. Ranjan emphasizes the importance of addressing risk factors like chronic urinary tract infections and urethral strictures. Maintaining good urinary health, avoiding tobacco use, and seeking timely treatment for urinary symptoms can help reduce the risk of urethral cancer.